A global phase 2/3, randomized, open-label trial of BNT327/PM8002 in combination with chemotherapy (chemo) in first-line (1L) non-small cell lung cancer (NSCLC).

Authors: Solange Peters, Stephen V. Liu, Vinod Ganju, Suzanne Kosmider, Se-Hoon Lee, Mehmet Ali Nahit Sendur, Yvonne J. Summers, Nicolas Girard, Yotsawaj Runglodvatana, Hasna Bouchaab, Ilhan Celik, Ulug Mutlu Gunaydin, René Bartz, Sarita Koride, Li Li, Claudia-Nanette Gann, Ugur Sahin, Özlem Türeci, Shun Lu

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps8670

Source: Full article

---

Abstract

TPS8670